AMPH – amphastar pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Amphastar Pharmaceuticals Highlights Baqsimi Milestones, Primatene Growth at Needham Conference [Yahoo! Finance]
Amphastar Pharmaceuticals (AMPH) was downgraded by Weiss Ratings from "hold (c-)" to "sell (d+)".
Amphastar Pharmaceuticals (AMPH) had its price target lowered by Barclays PLC from $30.00 to $23.00. They now have an "equal weight" rating on the stock.
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Amphastar Pharmaceuticals: Why I Like Bull Put Options Strategy Here [Seeking Alpha]
Form ARS Amphastar Pharmaceutical For: Dec 31
Form DEFA14A Amphastar Pharmaceutical
Form DEF 14A Amphastar Pharmaceutical For: Jun 01
Form SCHEDULE 13G/A Amphastar Pharmaceutical Filed by: VANGUARD GROUP INC
Form 4 Amphastar Pharmaceutical For: Mar 15 Filed by: Liawatidewi Yakob
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.